Brenda Cooper, MD
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 (NCT02890758) | Brenda Cooper, MD | 2018-05-22 |
| Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia (NCT01093573) | Brenda Cooper, MD | 2009-07-01 |
Track Brenda Cooper, MD automatically
Every clearance here is in the API, with alerts when new ones post.